Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

• Váldodahkkit: Patrick McMullan (Dahkki), Vamadevan S. Ajay (Dahkki), Ravi Srinivas (Dahkki), Sandeep Bhalla (Dahkki), Dorairaj Prabhakaran (Dahkki), Amitava Banerjee (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: In India, 50-65% of the population face difficulties in accessing medicines. The Health Impact Fund (HIF) is a novel proposal whereby pharmaceutical companies would be paid based on the measured global health impact of their drugs. We conducted a key stakeholder analysis to explore acces...